ABBV vs GE: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and GE Aerospace — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-29.
AbbVie Inc. · Healthcare
$197.69
+6.3% upside to fair value
Grade C
High Quality
VS
GE Aerospace · Industrials
$284.60
-24.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
ABBV has more upside to fair value
(+6.3%).
GE trades at a lower forward P/E
(34.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
GE |
| Current Price |
$197.69 |
$284.60 |
| Fair Value Estimate |
$210.22 |
$216.30 |
| Upside to Fair Value |
+6.3%
|
-24.0%
|
| Market Cap |
$349.7B |
$297.4B |
| Forward P/E |
83.3x
|
34.1x
|
| EV / EBITDA |
23.4x
|
27.9x
|
| Price / Sales |
5.7x
|
6.2x
|
| Price / FCF |
18.7x
|
39.8x
|
| Revenue Growth YoY |
+10.0%
|
+24.7%
|
| Gross Margin |
70.2%
|
34.8%
|
| Operating Margin |
26.7%
|
18.5%
|
| Return on Equity |
-361.6%
|
46.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
5.35%
|
2.51%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology, neuroscience, oncology, and aesthetics. The company benefits from a durable competitive moat driven by blockbuster drugs such as Skyrizi and Rinvoq, which are experiencing rapid growth and offsetting declines from Humira due to biosimilar competition. Despite a high trailing and forwa…
GE Aerospace is a leading player in the aerospace and defense industry, specializing in jet engines and propulsion technologies with a strong presence in commercial engines and defense propulsion segments. The company benefits from a high-quality management team led by CEO H. Lawrence Culp, Jr., who has extensive experience in operational transformation and aerospace leadership. Despite a premium…
Accumulation Zones
| Metric |
ABBV |
GE |
| Zone Low |
$157.66 |
$162.23 |
| Zone High |
$178.69 |
$183.86 |
| In Buy Zone? |
No
|
No
|